» Articles » PMID: 25302625

Respiratory Syncytial Virus (RSV) and Its Propensity for Causing Bronchiolitis

Overview
Journal J Pathol
Specialty Pathology
Date 2014 Oct 11
PMID 25302625
Citations 74
Authors
Affiliations
Soon will be listed here.
Abstract

Infants and young children with acute onset of wheezing and reduced respiratory airflows are often diagnosed with obstruction and inflammation of the small bronchiolar airways, ie bronchiolitis. The most common aetological agents causing bronchiolitis in young children are the respiratory viruses, and of the commonly encountered respiratory viruses, respiratory syncytial virus (RSV) has a propensity for causing bronchiolitis. Indeed, RSV bronchiolitis remains the major reason why previously healthy infants are admitted to hospital. Why RSV infection is such a predominant cause of bronchiolitis is the subject of this review. By reviewing the available histopathology of RSV bronchiolitis, both in humans and relevant animal models, we identify hallmark features of RSV infection of the distal airways and focus attention on the consequences of columnar cell cytopathology occurring in the bronchioles, which directly impacts the development of bronchiolar obstruction, inflammation and disease.

Citing Articles

Respiratory Syncytial Virus Burden in Premature Infants: The Role of Season With and Without RSV Immunoprophylaxis in a Multicenter Study.

Domany K, Mandelberg A, Burrack N, Golan-Tripto I, Masarweh K, Gur M Pediatr Pulmonol. 2025; 60(3):e71022.

PMID: 40042149 PMC: 11881211. DOI: 10.1002/ppul.71022.


Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care.

Sarna M, Le H, Taye B, Glass K, Levy A, Richmond P BMJ Open Respir Res. 2024; 11(1).

PMID: 39694679 PMC: 11667329. DOI: 10.1136/bmjresp-2024-002613.


Enhanced susceptibility of pediatric airway epithelium to respiratory syncytial virus infection.

Pickles R, Chen G, Randell S J Clin Invest. 2024; 134(21).

PMID: 39484717 PMC: 11527439. DOI: 10.1172/JCI185689.


Activation of STAT3-mediated ciliated cell survival protects against severe infection by respiratory syncytial virus.

Zhao C, Bai Y, Wang W, Amonkar G, Mou H, Olejnik J J Clin Invest. 2024; 134(21).

PMID: 39484716 PMC: 11527452. DOI: 10.1172/JCI183978.


Clinical and economic inpatient burden of respiratory syncytial virus (RSV) infections in children < 2 years of age in Germany, 2014-2019: a retrospective health claims analysis.

Lade C, Bayer L, Huebbe B, Riedel J, Melnik S, Brestrich G Infection. 2024; 53(1):393-404.

PMID: 39325356 PMC: 11825532. DOI: 10.1007/s15010-024-02391-x.


References
1.
Olivier A, Gallup J, Van Geelen A, Ackermann M . Exogenous administration of vascular endothelial growth factor prior to human respiratory syncytial virus a2 infection reduces pulmonary pathology in neonatal lambs and alters epithelial innate immune responses. Exp Lung Res. 2011; 37(3):131-43. PMC: 3169812. DOI: 10.3109/01902148.2010.484518. View

2.
Monto A, Malosh R, Petrie J, Thompson M, Ohmit S . Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. J Infect Dis. 2014; 210(11):1792-9. PMC: 4296188. DOI: 10.1093/infdis/jiu327. View

3.
Papin J, Wolf R, Kosanke S, Jenkins J, Moore S, Anderson M . Infant baboons infected with respiratory syncytial virus develop clinical and pathological changes that parallel those of human infants. Am J Physiol Lung Cell Mol Physiol. 2013; 304(8):L530-9. PMC: 3625990. DOI: 10.1152/ajplung.00173.2012. View

4.
Hall C . Respiratory syncytial virus and parainfluenza virus. N Engl J Med. 2001; 344(25):1917-28. DOI: 10.1056/NEJM200106213442507. View

5.
DeVincenzo J, Whitley R, Mackman R, Scaglioni-Weinlich C, Harrison L, Farrell E . Oral GS-5806 activity in a respiratory syncytial virus challenge study. N Engl J Med. 2014; 371(8):711-22. DOI: 10.1056/NEJMoa1401184. View